Evaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)
NCT ID: NCT05615181
Last Updated: 2025-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
310 participants
OBSERVATIONAL
2020-12-22
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
What Information is Remembered by Parents Following the Ingestion of Foreign Body by Their Child?
NCT05652166
Multisite Feeding Study: Home Surveillance and Feeding Strategies in Infants With Complex Single Ventricle
NCT00257517
Infants Colics : Towards a Migrainous Origin ?
NCT03155360
Retrospective Assessment of Referral of a Major Trauma Patient
NCT06551350
Overview of Telemedicine in Children With Type 1 Diabetes
NCT05348551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Gothenburg Trismus Questionnaire (GTQ) is a Patient Reported Outcome, validated in English, portuguese and sweden language.
The aim of this study is to develop a new tool in french language and to evaluate the specific impact of trismus on quality of life .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years old
* Read, write and understand the French language
Exclusion Criteria
* Refusal to participate in research
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Göteborg University
OTHER
Centre Hospitalier de Valence
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ch Valence
Valence, Drome, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIPH-CHV-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.